Latest News and Press Releases

Castle announced the recent publication of prospective data demonstrating the significant impact of DecisionDx-Melanoma on SLNB decision-making.

Castle will present data on DecisionDx-Melanoma at the 11th World Congress of Melanoma and 21st European Association of Dermato-Oncology (EADO) Congress.

DENVER, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Several prominent dermatology clinics in Colorado have united under the new parent brand, Cara Mia Dermatology, to reflect a comprehensive approach to...

New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- A biopsy is a procedure where a small amount of tissue is extracted for examination under a microscope. In the case of a core biopsy,...

Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma

InstaNatural is expanding its popular Vitamin C-infused skincare line to include three new suncare products.

London (UK), September 19 2024 – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class...

Schaumburg, Ill., Sept. 18, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA), in conjunction with the American Academy of Dermatology Association (AAD), the...

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 Monotherapy...

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy aging, is pleased to...